======= LANCL2 ======= == Gene Information == * **Official Symbol**: LANCL2 * **Official Name**: LanC like 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55915|55915]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NS86|Q9NS86]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LANCL2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LANCL2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612919|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Necessary for abscisic acid (ABA) binding on the cell membrane and activation of the ABA signaling pathway in granulocytes. {ECO:0000269|PubMed:19667068}. |LANC like| |regulation of response to alcohol| |positive regulation of abscisic acid-activated signaling pathway| |positive regulation of response to alcohol| |regulation of abscisic acid-activated signaling pathway| |positive regulation of cellular response to alcohol| |regulation of cellular response to alcohol| |phosphatidylinositol-5-phosphate binding| |phosphatidylinositol-4-phosphate binding| |phosphatidylinositol-3-phosphate binding| |catalytic activity| |cortical actin cytoskeleton| |GTP binding| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |ATP binding| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |positive regulation of signal transduction| |negative regulation of gene expression| |positive regulation of cell communication| |positive regulation of signaling| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|-2.18| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|-1.82| |[[:results:exp292|Menadione 5μM R06 exp292]]|-1.74| |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-1.74| |[[:results:exp462|Cadmium 60μM R08 exp462]]|1.75| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.75| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|1.76| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|1.92| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|1.99| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|2.02| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|2.3| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|2.31| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.41| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.76| |[[:results:exp111|R-DABN 8μM R03 exp111]]|2.88| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4548 * **Expression level (log2 read counts)**: 4.33 {{:chemogenomics:nalm6 dist.png?nolink |}}